Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in platinum-sensitive, recurrent ovarian cancer patients previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial | JOURNAL OF GYNECOLOGIC ONCOLOGY |